Reify Health’s Referral Partner Interface to Increase Efficiency in Patient Recruitment | Business

BOSTON – (BUSINESS WIRE) – May 24, 2021 –

Reify Health, a leading provider of cloud solutions that strengthen the clinical trial ecosystem, today announced the continued global deployment of its Reference Partner Interface (RPI), to simplify patient recruitment workflows and increase the efficiency of centralized recruitment campaigns. Proprietary technology allows third-party patient referrals to be delivered directly into Reify Health‘s StudyTeam â„¢, providing a common platform for sites and sponsors to manage pre-screening, enrollment and reporting for clinical trials and connects patients with the right trial at the right time.

There are more options and resources than ever for biopharmaceutical sponsors to recruit patients into clinical trials. However, this patchwork of options creates complexity for search sites as they have to deal with an increasing number of referral sources. StudyTeam RPI dramatically streamlines on-site recruiting workflows, automatically sending referrals directly into StudyTeam so that all candidates can be managed in one place. With RPI, sites no longer need to log into separate portals to manage referral statuses, or manually pull patient information from disparate systems such as EMRs, email, social media, and more. advertising campaigns in their workflow.

For sponsors, the interface allows confidence in trial recruiting. RPI provides real-time visibility and control over recruiting strategies. Sponsors understand major referral channels and can take steps to reduce lost patient referrals, while creating less work for sites. Recruiting providers also benefit from an efficient workflow and increased engagement. Reify Health‘s RPI establishes a meaningful connection between all parties to enable effective clinical trials and deliver treatment to patients faster.

“At Reify, we continually work to overcome traditional bottlenecks in the clinical trial ecosystem. This is exactly what the introduction of our referral partner interface does, ”said Jai Singh, vice president of site adoption at Reify Health. “StudyTeam RPI minimizes lost referrals, reduces the data entry load for sites, provides sponsors with earlier and more accurate visibility into the performance of their recruiting strategies, and provides reports to recruiting providers detailing the status of their references. Sites, sponsors and referral providers benefit from the right tools and access to more patients. At the end of the day, that’s what we’re trying to solve.

StudyTeam is the patient registration management platform chosen by more than 3000 sites and 7 of the 10 largest global biopharmaceutical sponsors. Its integrated RPI is an additional added value and offers extensive benefits through partnerships, including with SubjectWell.

To learn more about StudyTeam RPI, click on here.

About Reify Health

Reify Health provides cloud-based software that accelerates the development of new and life-saving therapies. Reify serves the global life sciences industry, including thousands of clinical research sites, the world’s most innovative biotechnologies and the world’s largest biopharmaceutical companies. The global healthcare system is relying on clinical trials to develop new life-saving treatments for patients. Reify Health’s StudyTeam software empowers both research sponsors who advance clinical trials and physicians and research coordinators who care for volunteer patients so they can devote more focus and time to work which results in successful clinical research. To learn more, visit

View source version on

CONTACT: Katie Johnston

[email protected]



SOURCE: Reify Health

Copyright Business Wire 2021.

PUB: 05/24/2021 9:01 a.m. / DISC: 05/24/2021 9:02 a.m.

Copyright Business Wire 2021.

About Terry Gongora

Check Also

Fighting antimicrobial resistance does not involve miracle drugs

Antibiotic sensitivity test. [iStockphoto] Africa, like other continents, has a problem with antimicrobial resistance (AMR). …

Leave a Reply

Your email address will not be published.